Meeting Announcement - Chongqing Porton Pharmaceutical Technology Co., Ltd. will hold its first extraordinary general meeting of shareholders in 2025 on September 8, 2025, at 14:30 [1][2] - The meeting will be convened by the company's board of directors and complies with relevant laws, regulations, and the company's articles of association [1][2] Voting Procedures - The meeting will utilize a combination of on-site voting and online voting, with shareholders required to choose one method to exercise their voting rights [2][3] - Shareholders registered by the close of business on September 1, 2025, will be eligible to vote [2][3] Meeting Agenda - The agenda includes proposals that have been approved by the board during its third meeting, with specific details available in the company's announcements [4][5] - Proposal 1 and Proposal 2 require a special resolution, needing more than two-thirds of the voting rights held by attending shareholders to pass [6] Registration and Attendance - Shareholders must present identification and relevant documents to register for the meeting, with specific requirements for individual and corporate shareholders [6][7] - Registration for on-site attendance will be available from 8:30 to 17:00 on September 3, 2025, and remote registration must be completed by the same date [7] Online Voting - Shareholders can participate in online voting through the Shenzhen Stock Exchange's trading system or internet voting system, with detailed procedures provided in the attachments [9][10] - The online voting will allow shareholders to express their opinions on the proposals, with the first valid vote being counted in case of duplicate submissions [9][10]
博腾股份: 关于召开2025年第一次临时股东会的通知